Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > S&P Biotech ETF is now up ~3% this year

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Dec 13, 2023 5:50pm

161 Views

Post# 35783274

S&P Biotech ETF is now up ~3% this year

The S&P Biotech ETF is up about 31% in the last 1 1/2 months. One month ago MBX.to was trading at $.23 and is now up 65% in one month. The S&P Biotech ETF is now up ~3% this year and MBX.to was $.41 at the start of the year. MBX.to is therefore still down 7.3% this year despite the closing of the Kinlytic deal.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1